Objective: To objectively assess the effect of transitional care on readmission for patients with chronic obstructive pulmonary disease. Methods: The PubMed, Science Direct, Web of Science, Cochrane Library, CNKI, and Wanfang databases were searched for relevant randomized controlled trials (RCTs) published from January 1990 through April 2016. The quality of eligible studies was assessed by two investigators. The primary outcome assessed was readmission for COPD and all-cause readmission. The pooled effect sizes were expressed as the relative risk and standard mean difference with 95% confidence intervals. Heterogeneity among studies was assessed using the Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0) and determined with an I 2 statistic.
Introduction
Chronic obstructive pulmonary disease (COPD) is a common disease worldwide that is characterized by chronic airflow limitation and a range of pathological changes in the lung, some heavy extra-pulmonary effects, and important comorbidities that may contribute to the severity of the disease in individual patients. 1 It has been estimated that COPD will be the third leading cause of death worldwide by 2030. 2 Readmissions are a significant source of morbidity and a heavy healthcare burden. According to statistics, readmission among elderly patients with COPD costs approximately $924 million annually. 3 Unplanned readmission for COPD has exhibited an upward yearly trend, occurring in almost one in five discharges among older adults. 4 The reasons for readmission of COPD patients are complex and include frequent acute exacerbations, coexisting comorbidities, and lack of transitional care. 5 Nurses and other healthcare providers, as a part of a multidisciplinary team, can play a key role in COPD care by developing an individualized needs-based comprehensive discharge plan, connecting patients and outpatient providers, providing educational and behavioral interventions, managing symptoms and providing direct patient care, monitoring patients and caregivers regularly through home visits and/or telephone contact, providing counseling and self-care instruction, and reviewing and managing medications during transitions from one setting to another, especially from the hospital to home. For example, discharged patients with COPD may present with severe breathlessness, expectoration and chronic productive cough, 6 and they may not be aware of their worsening status or the necessity of awareness of self-care, ongoing monitoring, and care coordination. As a result, they require professional education to identify risks, especially in the selfassessment of the acute exacerbated stage of COPD signs and symptoms as well as adherence to self-care maintenance recommendations. Transitional care executors play a critical role in narrowing these potential gaps when transitioning COPD patients from one care setting to another. Regarding the effect of transitional care on readmission reduction, there have been many studies on the relationship between transitional-care models and the readmission reduction effect among patients with COPD, but the results of different trials have not been consistent. 7 Therefore, the aim of this review is to study the effects of transitional-care models on readmission reduction for patients with COPD moving from the hospital to home and to provide guidance to transitional care providers in developing and implementing appropriate processes that may promote a reduction in readmissions.
Methods

Search strategies
A research librarian was consulted to search for and identify articles related to our study. The PubMed, Science Direct, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), and Wan-fang databases were searched. The PubMed search was conducted using the following algorithm: [ [tw] ). Other databases were searched using a similar search strategy. In PubMed, we conducted searches in all fields and identified 101 articles. In other databases, we conducted searches in the title/ abstract/keyword fields and identified 145 articles from Science Direct; 163 from Web of Science; 97 from the Cochrane Library; 56 from CNKI; and 41 from the Wanfang Database. Searches were limited to English language articles published from January 1990 through April 2016. Articles had to include patients with COPD exclusively and have at least 1 transition component from one setting to another. In addition, the reference lists and academic conference literature were manually searched, and experts in the clinical nursing field were consulted to locate additional studies.
The literature search consisted of four steps: (1) Searches of systematic literature studies relevant to COPD transition were conducted in the Cochrane and JBI libraries; (2) The titles, abstracts, keywords and subjects of original articles retrieved from PubMed, Science Direct and Web of Science were analyzed to further confirm retrieval of keywords and subjects; (3) relevant databases were searched by keywords and subjects, and full-text articles whose abstracts met the inclusion criteria were retrieved; and (4) references from the obtained articles were further retrieved.
Inclusion criteria and study selection
Studies were included if they met the following criteria: (1) Patients who reached the age of 18 were diagnosed with COPD, patients in the intervention group who accepted post-discharge transitional care, and other patients in the control group who accepted usual care without post-discharge transitional care; patients with asthma as a primary diagnosis and with major comorbidities (e.g., serious heart failure, malignant or terminal disease) were excluded as were patients with dementia or uncontrolled psychiatric illness. (2) The interventions in the articles included in this review were: patient situation and homecare needs assessment before discharge; after discharge, a specific transition executor provided individual care to patients with COPD by telephone and/or home visit. Patients could also contact the executor for further information during the intervention period. (3) The outcomes in the studies were classified as readmissions for COPD and all-cause readmissions. Fig. 1 shows the selection process for the final 7 articles for this review. An additional 136 additional full-text articles were excluded: 73 articles with incomplete readmission data, 29 articles with incomplete intervention group/control group (IG/CG) data, and 34 articles for other reasons. We originally retrieved these articles for meta-analysis between January 1990 and April 2016, and all of the articles investigated readmission as an outcome of transitional care for patients with COPD.
Data extraction and quality assessment
Data from the 7 studies were extracted by one of the two reviewers (Liu) with a standard data extraction form. All of the data extracted from these studies were checked by the other reviewer (Zhang). We adopted the Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0) 8 to assess the risk of bias, which includes six domains: selection bias, performance bias, detection bias, attrition bias, reporting bias and other bias. Two reviewers (Liu and Zhang) assessed each study independently and consulted in the case of disagreements, all of which were then resolved by consensus.
Statistical method
Software Review Manager version 5.3 was used to conduct statistical analysis. The heterogeneity between studies was evaluated by the I 2 test. If I 2 < 50%, the possibility of heterogeneity between studies was low and the fixed effect model could be utilized. If I 2 > 50%, there was heterogeneity between studies and the sources of heterogeneity should be analyzed. The criteria for significance were P < 0.05 and 95% CI not including 0.
Results
Systematic review
3.1.1. Characteristics of the selected studies Seven articles identified as part of the systematic literature searches are summarized in Fig. 1 . Based on a thorough review of this literature, 7 articles 9e15 in the review included a total of 1879 participants. Table 1 presents the characteristics and pulmonary functions. The number of participants of each study ranged from 184 11 to 464. 15 All participants had COPD. In these studies, the mean age was over 65 years old. In 2 studies, 11,15 the participants were British, 2 other studies 10, 13 reported that the participants were Canadian, and 3 further studies reported 9,12,14 adult participants from Slovenia, the Netherlands and the United States. The intervention duration ranged from 6 months 9,12,14 to 24 months. 10 One study 10 had more than one follow-up interval that ranged from 12 to 24 months. Six studies 9,11e15 investigated readmissions for COPD, and 4 studies 9e11,15 investigated all-cause readmissions. One 12 reported blinding of participants. The individual quality of most studies revealed a low bias risk in most domains, and all of the studies were judged to have a high risk of bias in at least one domain (Fig. 2) . Six studies presented approved random sequence generation, 9,11e15 and five presented allocation concealment. 9,11e13,15 No study reported blinding of outcome assessment, but five studies reported incomplete outcome data. 9,10,13e15 Two studies reported a selective reporting bias, 9, 15 and two studies seemed to be free from other risks of bias. 11, 15 Finally, after discussion with a third author, the agreement was 100%.
Overall results of the transitional care effect
All 7 studies provided related data of readmission as the outcome measure of transitional care intervention effect. In 6 studies, 9,11e15 we used readmission for COPD to represent the effect of intervention, and in 3 studies, 9, 11, 15 we used all-cause readmission to represent the effect of intervention. Three studies, 9, 12, 14 however, only provided the results of a 6 month follow-up, 2 studies 13,15 provided the results of a 12 month followup, 1 study 11 provided the results of an 18 month follow-up, and 1 study 10 provided the results of 12 and 24 month follow-up.
Results of subgroup analysis
We divided the results into three mutually exclusive groups (readmission for COPD in 6 months, readmission for COPD in 18 months, all-cause readmission in 18 months) based on the reason for readmission and intervention duration to perform the subgroup analysis (Fig. 3) . In the readmission for COPD in 6 months, 9, 12, 14 there was no heterogeneity (P ¼ 0.54, I
2 ¼ 0%) and the fixedeffect model was selected. Meta-analysis showed that transitional care can reduce readmission for COPD in 6 months [RR ¼ 0.51, 95% CI (0.38, 0.68), P < 0.00001] (Fig. 3, Section A) . In the readmission for COPD in 18 months group, 9,11e14 given that the control group patients in a study accepted extra care outside the hospital, this may have contributed to the small differences between groups in the meta-analysis, and we therefore did not include this research in the subgroup analysis. 15 There was no heterogeneity (P ¼ 0.66, I 2 ¼ 0%), the fixed-effect model was selected, and meta-analysis showed that transitional care can reduce readmission for COPD in 18 months [RR ¼ 0.56, 95% CI (0.45, 0.69), P < 0.00001] (Fig. 3,  Section A) . In the all-cause readmission in 18 months group, 9, 11, 15 there was no heterogeneity (P ¼ 0.25, I 2 ¼ 28%), the fixed-effect model was selected, and meta-analysis showed that transitional care can reduce all-cause readmission [RR ¼ 0.72, 95% CI (0.62,0.84), P < 0.0001] (Fig. 3, Section B) .
Discussion
Methodological quality of the included studies
In the 7 included studies, 6 articles 9,11e15 reported random sequence generation and 5 articles 9,11e13,15 reported the process of concealing allocation. Although only 1 article 12 blinded the participants, all of the articles adopted a blinded outcome assessment to avoid detection bias. Four articles 9,13e15 reported the intention to treat analysis, and 6 articles 9,10,12e15 compared clinical and sociodemographic characteristics between the intervention group and control group at baseline and described specific inclusion/exclusion criteria.
Effect of transitional care on readmission
Transitional care interventions have a significantly positive effect on reducing readmission for COPD in 6 months (95% CI 0.38 to 0.68, P < 0.00001) and in 18 months (95% CI 0.45 to 0.69, P < 0.00001), and there is less heterogeneity among these studies (both I 2 ¼ 0%). According to the subgroup analysis of all-cause readmission in 18 months, transitional care can also reduce allcause readmissions (95% CI 0.62 to 0.84, P < 0.0001) and there is acceptable heterogeneity among these studies (I 2 ¼ 28%). As mentioned in the introduction, readmission occurred in almost one in five discharged COPD patients. Therefore, the effect of transitional care on reducing readmission is crucial for patients with COPD.
The difference in the duration of transitional care intervention may influence the effect on transitional care. One study 10 included in our review showed the reduction in the rate of all-cause readmissions in the intervention group compared to the control group: the reduction was À0.1 (À0.27 to 0.07) in the preceding year, À0.70 (À0.95 to À0.46) in the first year follow-up, and À0.44 (À0.68 to À0.21) in the second year follow-up. Compared to the readmission difference between the control and intervention groups in the first and second year follow-up, however, the difference in the second year was less than that in the first year. The readmission difference in the preceding year was À6.3% and was À42.6% in the first year follow-up and À26.9% in the second year follow-up. One potential limitation is that during the second year of follow-up, transitional care intervention was not under strict protocol regulation as in the first year or the patients in intervention group were free from transition education. Thus, further long-term research in transitional care intervention should be executed in patients with COPD. The outcome measures used in the included studies can also be discussed. Readmission was one of the most commonly used outcomes for discharged COPD patients, who always experience a long disease duration. Other limitations should also be taken into account when interpreting the results. Some of the included studies had a high risk of bias for several domains, which may reduce the possibility of drawing any conclusion. All of the studies that we included were RCTs to decrease the risk of bias, however, and baseline data between the two groups were comparable. Because personnel care can be hardly blinded at all in this type of intervention, researchers should be careful to minimize the risk of bias.
Study limitations
There are still some limitations in our meta-analysis. First, although the 7 studies included are RCTs, 6 of those studies are not double blinded. Second, the control groups of some studies not only adopted usual care but also additional interventions, such as postdischarge education, counseling or hospital support, which may have compromised the sensitivity of the studies to detect the true effects of transitional care. Third, some subgroups in our subgroup analyses had a small number of studies. Fourth, we did not conduct subgroup analysis controlling for other influencing factors of transitional care, such as the intervention measures or intensity due to the limited number of studies.
Practice implications
Transitional care programs for patients with COPD should be extended. COPD is regarded as a significant public health concern that requires self-management strategies. Transitional care taught patients self-management skills and improved their ability to perform risk identification and acute exacerbation measurements, which were associated with readmission in adult patients with COPD. 16 Other suggestions from the present subgroup analyses include that the duration of transitional care should last !6 and 18 months and that methods to provide ongoing care should be developed. Moreover, more studies should verify the intervention components or executor skills and determine best practices. In addition, transitional care should be studied explicitly from the aspects of its executor, manner, duration of effect, intensity, intervention location, cost-effectiveness, and so on. Providing theories for how to maintain recommended self-care and management behaviors in patients' daily routines is also imperative. Finally, family caregivers and other social support systems can help facilitate adherence to the follow-up implementation.
Conclusions
In summary, transitional care in 7 studies achieves statistically significant benefits in reducing COPD related or all-cause readmission for patients with COPD. Durations of !6 and 18 months are more likely to be effective, and the effect of transitional care on readmission weakens over intervention time, especially after the end of intervention. Both of these findings point to the importance of ongoing intervention and the importance of reinforcement after the end of intervention.
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